DK421486A - Polydisperse native pseudomonas-flagella(h)-antigener (fag) og fremgangsmaade til deres udvinding - Google Patents

Polydisperse native pseudomonas-flagella(h)-antigener (fag) og fremgangsmaade til deres udvinding Download PDF

Info

Publication number
DK421486A
DK421486A DK421486A DK421486A DK421486A DK 421486 A DK421486 A DK 421486A DK 421486 A DK421486 A DK 421486A DK 421486 A DK421486 A DK 421486A DK 421486 A DK421486 A DK 421486A
Authority
DK
Denmark
Prior art keywords
antigens
flagellar
treatment
polydisperse
pseudomonas
Prior art date
Application number
DK421486A
Other languages
English (en)
Other versions
DK172329B1 (da
DK421486D0 (da
Inventor
Thomas C Montie
Friedrich Dorner
James L Mcdonel
Artur Mitterer
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of DK421486A publication Critical patent/DK421486A/da
Publication of DK421486D0 publication Critical patent/DK421486D0/da
Application granted granted Critical
Publication of DK172329B1 publication Critical patent/DK172329B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK421486A 1985-01-14 1986-09-03 Polydisperse, native Pseudomonas-flagella(H)-antigener (FAg) i polymer form og fremgangsmåde til deres udvinding DK172329B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AT0007285A AT384032B (de) 1985-01-14 1985-01-14 Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
AT7285 1985-01-14
PCT/AT1986/000002 WO1986003974A1 (en) 1985-01-14 1986-01-13 POLYDISPERSED NATIVE PSEUDOMONAS-FLAGELLA (H)-ANTIGENS (FAg) AND METHODS FOR THEIR PREPARATION
AT8600002 1986-01-13

Publications (3)

Publication Number Publication Date
DK421486A true DK421486A (da) 1986-09-03
DK421486D0 DK421486D0 (da) 1986-09-03
DK172329B1 DK172329B1 (da) 1998-03-23

Family

ID=3480790

Family Applications (1)

Application Number Title Priority Date Filing Date
DK421486A DK172329B1 (da) 1985-01-14 1986-09-03 Polydisperse, native Pseudomonas-flagella(H)-antigener (FAg) i polymer form og fremgangsmåde til deres udvinding

Country Status (10)

Country Link
US (1) US4831121A (da)
EP (1) EP0208743B1 (da)
JP (1) JPH085801B2 (da)
AT (2) AT384032B (da)
CA (1) CA1263307C (da)
DE (1) DE3686961D1 (da)
DK (1) DK172329B1 (da)
ES (1) ES8800275A1 (da)
FI (1) FI85221C (da)
WO (1) WO1986003974A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5237053A (en) * 1986-06-24 1993-08-17 Immuno Aktiengesellschaft Preparation active against Pseudomonas aeruginosa infections and methods of producing them
AT391080B (de) * 1986-06-24 1990-08-10 Immuno Ag Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen
AT390192B (de) * 1988-08-29 1990-03-26 Immuno Ag Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobuling-h|ltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen
US4994161A (en) * 1989-02-02 1991-02-19 University Of New Hampshire Apparatus and method for macromolecular charge determination
WO2005091716A2 (en) * 2004-03-26 2005-10-06 Quark Biotech, Inc. Annexin ii and uses thereof
US8263078B2 (en) 2007-09-05 2012-09-11 Inotek Pharmaceuticals Corporation Antibodies against flagellin and uses thereof
US20100239583A1 (en) * 2009-03-04 2010-09-23 Inotek Pharmaceuticals Corporation Antibodies against flagellin and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928565A (en) * 1971-10-19 1975-12-23 Yuzuru Homma Pharmaceutical preparation of pseudomonas aeruginosa bacterial component possessing anti-tumor and anti-infection properties
JPS51133489A (en) * 1975-05-14 1976-11-19 Tokyo Daigaku Process for producing microbial components of pseudomonas aeruginosa h aving antimicrobial and antitumor activities
FR2460139A1 (fr) * 1979-06-29 1981-01-23 Pasteur Institut Fraction antigenique glycopeptidique vaccinante a tres grande immunogenicite isolee de cultures de germes pathogenes, procedes d'isolement de cette fraction et vaccins contenant ladite fraction
US4271147A (en) * 1980-01-10 1981-06-02 Behringwerke Aktiengesellschaft Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same
EP0048422A3 (en) * 1980-09-15 1983-08-24 Bactex Incorporated Pili of pseudomonas aeruginosa and utilization of same as vaccines against infectionary p.aeruginosa
US4470924A (en) * 1981-12-30 1984-09-11 Iglewski Barbara M Nontoxic, immunologically crossreactive toxin A protein from Pseudomonas aeruginosa
US4578458A (en) * 1983-03-23 1986-03-25 Brigham And Women's Hospital Mucoid exopolysaccharide vaccine against Pseudomonas aeruginosa

Also Published As

Publication number Publication date
ES8800275A1 (es) 1987-11-01
AT384032B (de) 1987-09-25
JPS62501363A (ja) 1987-06-04
ATE81471T1 (de) 1992-10-15
US4831121A (en) 1989-05-16
JPH085801B2 (ja) 1996-01-24
DE3686961D1 (de) 1992-11-19
FI863677A0 (fi) 1986-09-11
CA1263307A (en) 1989-11-28
ES550831A0 (es) 1987-11-01
EP0208743A1 (de) 1987-01-21
CA1263307C (en) 1989-11-28
EP0208743B1 (de) 1992-10-14
FI863677A (fi) 1986-09-11
ATA7285A (de) 1987-02-15
FI85221C (fi) 1992-03-25
WO1986003974A1 (en) 1986-07-17
DK172329B1 (da) 1998-03-23
FI85221B (fi) 1991-12-13
DK421486D0 (da) 1986-09-03

Similar Documents

Publication Publication Date Title
Elsayed et al. Isolation of purified allergens (cod) by isoelectric focusing
Daniel et al. Mycobacterial antigens: a review of their isolation, chemistry, and immunological properties
Klemm et al. F7 and type 1-like fimbriae from three Escherichia coli strains isolated from urinary tract infections: protein chemical and immunological aspects
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
DE3686304D1 (de) Typenspezifische papillomavirus-dns-sequenzen und peptide.
FI101632B1 (fi) Menetelmä Bordetella pertussis-toksiinin alayksikön analogien valmistamiseksi ja niitä koodaavia rekombinantti-DNA-molekyylejä
ATE13741T1 (de) Ein spezifisches antigen enthaltender impfkomplex und ihn enthaltender impfstoff.
UA72199C2 (en) VACCINE CONTAINING AT LEAST ONE PARTICULATE IMMUNOGEN AND ADJUVANTING AMOUNT OF SUBUNITS OF e. COLI HEAT-LABILE ENTEROTOXIN (LTB) FREE FROM CONTAMINATING A SUBUNITS OR TOXIC HOLOTOXIN, ITS USE FOR INDUCTION OF LOCAL AND SYSTEMIC PROTECTIVE RESPONSE AGAINST PARTICULATE IMMUNOGEN UPON MUCOSAL ADMINISTRATION
ES2007720A6 (es) Procedimiento de obtencion de una vacuna a base de flagelo bacterial.
AU7752487A (en) Immunomodulating compositions and their use
NZ331989A (en) Arthritogenic peptide, DNAJ, isolated from bacterial peptides and used in vaccine compositions for treating rheumatoid arthritis
DK656687D0 (da) Bakterielle antigener, antistoffer, vacciner og fremgangsmaade til fremstilling deraf
DK421486A (da) Polydisperse native pseudomonas-flagella(h)-antigener (fag) og fremgangsmaade til deres udvinding
DE3380629D1 (en) Region-specific determinants for vitamin k dependent bone protein
Schechter et al. The requirement for tetravalency of soybean agglutinin for induction of mitogenic stimulation of lymphocytes
JPH03191789A (ja) 百日咳菌からの６９０００ダルトンの抗原性タンパク質の精製方法
Kahane et al. Isolation of a glycoprotein from Mycoplasma pneumoniae membranes
US3823126A (en) Process of separating human cancer antigen proteins by gel filtration
CA1270597A (en) Thf compositions
FR2517967B1 (da)
DE69534635D1 (de) Verfahren zur produktion von verstärkt antigen wirkenden heliobacter sp. und vakzine die diesen enthalten
IT1206250B (it) Stiche umane e relativi prodotti metodo per l'estrazione di antigeni di membrana aventi proprieta' immunogene a partire da cellule neopla-
Markussen et al. Separation and characterization of glucagon-like immunoactive components from gut extracts by electrofocusing
KR890000106A (ko) 원생성 기생충 예방용 백신
IE860758L (en) Anaplasma marginale subunit antigen for vaccination and¹diagnosis

Legal Events

Date Code Title Description
ATS Application withdrawn
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK